Oncotect
PrivateLast Round
Accelerator
Feb 27, 2023
Total Funding Raised
$360,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Oncotect operates in Healthcare & Life Sciences and is based in Raleigh, North Carolina. Its latest recorded funding round was an Accelerator round in February 2023.
Oncotect is a biotechnology company that provides a non-invasive, urine-based cancer screening test for dogs using nematode-based olfactory detection technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands
Business Model
B2C
Customer Profile
Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oncotect Comparables
Compare Oncotect with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProPetDx | 83% | |
| ScoutMD, Inc. | 83% | |
| Kedi Labs | 76% |
For institutional investors. Book with your work email.
Oncotect Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 27, 2023 | ||||
| Grant | Nov 15, 2022 | ||||
| Debt | Nov 1, 2022 | ||||
| Grant | May 3, 2022 |
For institutional investors. Book with your work email.
Oncotect Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NC IDEA | Grant |
| R/GA Ventures | Accelerator |
| Leap Venture Studio | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 99% MoM, reaching 9.1K.
- Apr 1, 2026
Monthly visitors increased 66% MoM.
For institutional investors. Book with your work email.
Oncotect Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oncotect's valuation, stock price, and market status.
Is Oncotect a public or private company?
Oncotect is a private company.
What is the current stock price of Oncotect?
Oncotect is a private company, so its shares have no public market price. Caplight tracks Oncotect's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oncotect worth (valuation)?
Valuation information for Oncotect is not publicly available.
Can I buy Oncotect stock?
Oncotect shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oncotect's last funding round?
Oncotect's most recent funding round was Accelerator on February 27, 2023.
Who are the main investors in Oncotect?
Key investors in Oncotect include NC IDEA, R/GA Ventures, Leap Venture Studio.
Will Oncotect IPO soon?
No public IPO plans have been announced for Oncotect.
How can I track Oncotect secondary market activity?
Caplight tracks bids, offers, and trades in Oncotect's shares on secondary markets.